undamentalytics Newsletter
Sign in

Elutia Inc. income statement

In fiscal 2025, Elutia Inc. reported revenue of $12.3m, down 15.0% on the year before, operating income of −$26.9m (a -218.9% margin) and net income of $53.4m, or $0.87 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue4343472425141212
Cost of revenue2322281214865
Gross profit2021191211777
Research and development26984347
Selling and marketing1618191813566
General and administrative1011141614181515
Operating income−8−14−23−35−31−31−27−26
Interest expense565565——
Income before tax−12−22−25−36−41−45−16−22
Income tax00000000
Net income−12−22−25−33−38−545352
Diluted EPS−$18.48−$8.88−$2.38−$2.38−$2.07−$1.86$0.87$1.14
Diluted shares (average)—3m10m14m18m29m46m45m
EBITDA−5−10−19−31−27−27−24−24

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: ELUT vs HSDTELUT vs NNOXELUT vs NSPR

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Elutia Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Elutia Inc.